In a new study out of Germany, scientists discovered that peptides found in the mucus of axolotls—a wild-looking salamander famous for regenerating limbs—can selectively kill breast cancer cells 🎗️ and destroy antibiotic-resistant bacteria like MRSA (methicillin-resistant Staphylococcus aureus) 🦠.

Read Full Article

#AxolotlResearch #CancerTreatment #AntibioticResistance #PeptideScience #RegenerationMagic

Study finds molecular "seesaw" involving 2 proteins in lung cancer cells, AXL & FN14. When one is blocked the other takes over and helps the tumor survive. A gelatin-based nanoparticle treatment was developed that shuts down both proteins, and shows promising results in early studies with mice. 🧬🦠💊🐭

Read Full Article

#LungCancerResearch #NanoparticleTherapy #AXLFN14 #CancerTreatment #MedicalBreakthroughs

Sugar compound from deep-sea bacteria (Spongiibacter nanhainus CSC3.9) revealed to cause cancer cells to explosively self-destruct through pyroptosis 💥🦠🔬

Read Full Article

#DeepSeaResearch #CancerTreatment #Pyroptosis #BacterialCompounds #ScientificBreakthrough

TL;DR: A single-bag protocol for treating cancer drug allergies is just as safe as the 3-bag standard, could save 2-3 hours per treatment, and might be a lifesaver for under-resourced hospitals. 🏥💉⏳✨

Read Full Article

#CancerTreatment #DrugAllergies #HealthcareInnovation #MedicalResearch #PatientCare

Scientists have engineered Salmonella bacteria to self-destruct inside tumors, releasing signals that spark powerful immune hubs and shrink colon cancer in mice, opening the door to “living medicines” against deadly cancers. 🦠💊🧬🦠

Read Full Article

#SalmonellaResearch #CancerTreatment #Immunotherapy #LivingMedicines #ColonCancerAwareness

Blocking newly discovered enzymes could boost prostate cancer treatment 🧬🔬 | Scientists have identified a pair of enzymes (PDIA1 and PDIA5) that can be targeted for a quicker and more effective treatment of a condition that affects 1.5 million men around the world annually. 🌍👨‍⚕️

Read Full Article

#ProstateCancer #EnzymeResearch #CancerTreatment #HealthInnovation #MensHealth

New cancer treatment combines LED light 💡 and tiny tin flakes 🪙 to kill cancer cells, spare healthy cells and avoid side effects of chemotherapy. In just 30 minutes, it killed up to 92% of skin cancer cells 🎗️ and 50% of colorectal cancer cells, without harmful effects on healthy human skin cells.

Read Full Article

#CancerTreatment #LEDLightTherapy #InnovativeMedicine #HealthyCells #CancerResearch

We published a safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation that achieved complete cancer regression. 💉🔬✨💊🌟

Read Full Article

#CancerResearch #LiposomalNanotechnology #Anthracycline #CancerTreatment #DrugDelivery

Nasal Drops Fight Brain Tumors Noninvasively: Nasal drops deliver potent tumor-fighting nanomedicine to the brain 🧠💧 and eradicate glioblastoma, one of the most aggressive and deadly brain cancers, in mice 🐭. Glioblastoma is the most common kind of brain cancer and is almost always fatal.

Read Full Article

#NasalDrops #BrainTumorResearch #Glioblastoma #Nanomedicine #CancerTreatment

Cancer cells evade apoptosis, or programmed cell death. Inducing apoptosis in cancer may be less toxic to healthy tissue than chemotherapy or radiation. Japanese scientists discovered that when a microbial protein is exposed to green light, it induces apoptosis in cancer-specific cell lines in mice. 💡🦠💚✨

Read Full Article

#CancerResearch #Apoptosis #MicrobialProtein #GreenLightTherapy #CancerTreatment

Scientists uncover key driver of treatment-resistant cancer: 🧬 « UC San Diego scientists discover enzyme responsible for scrambling cancer genomes; results could enable new treatments for the most aggressive cancers. 💊🔬 »

Read Full Article

#CancerResearch #TreatmentResistance #Genomics #CancerTreatment #UCSanDiego

🔬 New Blood Test Predicts Breast Cancer Treatment Response
A simple DNA blood test developed by researchers at the Institute of Cancer Research, London (ICR) can predict how well breast cancer patients will respond to treatment, potentially allowing for faster, more personalized care and avoiding ineffective therapies.

🔬 How it Works & Early Results
The test analyzes circulating tumor DNA (ctDNA) released by cancer cells into the blood. In a study of 167 patients with advanced breast cancer, low ctDNA levels at the start of treatment were strongly associated with a better response. For one group, low ctDNA was linked to 10.2 months of progression-free survival versus 4.4 months with higher levels.

🔬 Four-Week Check-in Shows Promise
A follow-up analysis after just one treatment cycle also showed strong links between ctDNA levels and patient outcomes. Patients with undetectable ctDNA after four weeks saw their cancer kept at bay for significantly longer periods compared to those with detectable levels.

#BreastCancer #MedicalResearch #CancerTreatment

⚡️ FLASH radiotherapy uses ultrahigh-power radiation bursts (under 0.1 second) to target tumors while significantly reducing damage to healthy tissue, a stark contrast to conventional radiation therapy delivered over weeks.

🔬 Research originating from Institut Curie in the 1990s by Vincent Favaudon and Marie-Catherine Vozenin revealed that extremely fast, high-dose radiation (10 Gray or more) could eradicate tumors in mice with minimal harm to surrounding tissue.

⚙️ Scientists at CERN, SLAC, and other labs are adapting high-energy physics tools and accelerators to develop machines capable of delivering FLASH therapy with the precision and speed required for clinical use, potentially transforming cancer treatment.

🐶 Preclinical studies are ongoing at facilities like PITZ in Germany, utilizing animal models (zebra fish and mice) to systematically optimize FLASH parameters and understand its biological effects.

#FLASHtherapy #CancerTreatment #MedicalPhysics

Breast cancer patients who rely only on alternative medicine are ~4× more likely to die

Read Full Article

#BreastCancerAwareness #CancerTreatment #MedicalNews

🔬 New experimental cream shows promise in preclinical studies to prevent or slow the growth of certain common skin cancers, specifically cutaneous squamous cell carcinoma (cSCC).

🛡️ The cream works by blocking an enzyme called LSD1, which normally suppresses the skin's immune defenses. By blocking LSD1, the cream activates the immune system to attack tumors.

📅 Researchers at the Perelman School of Medicine at the University of Pennsylvania are refining the cream's formula and aim to begin a phase 1 clinical trial within the next 1-2 years.

#SkinCancer #MedicalResearch #CancerTreatment

✅ A new phase III clinical trial, published March 11, 2026, in the New England Journal of Medicine, shows Nplate (romiplostim) can improve platelet counts and reduce recurrence of thrombocytopenia in patients with gastrointestinal cancers.

✅ In the study, 84% of patients receiving Nplate avoided chemotherapy dose adjustments related to low platelets, compared to 36% in the placebo group, allowing them to stay on their treatment schedule.

✅ Nplate works by stimulating bone marrow cells to produce more platelets, potentially making cancer treatment safer and more effective.

✅ While serious side effects occurred in 37% of Nplate users (attributed mostly to chemotherapy), only 12% experienced drug-related symptoms like nausea and headache. No Nplate-related side effects led to treatment discontinuation or death.

#CancerTreatment #Oncology #MedicalBreakthrough

🔬 New research from CU Anschutz may explain why cancer patients experience taste changes during treatment. Targeted drugs called tyrosine kinase inhibitors (TKIs) don't damage taste buds but shift their cell composition, reducing sweet taste detection and enhancing bitter/savory perception.

🔬 The study identified a protein called KIT as the key. TKIs unintentionally block KIT, a regulator of taste cell development, leading to fewer sweet-sensing cells and more bitter/umami-sensing cells, distorting overall flavor perception.

🔬 This taste alteration (dysgeusia), affecting 10-50% of patients on TKIs, can lead to loss of appetite, weight loss, poor nutrition, social withdrawal, and depression.

🔬 Researchers are exploring solutions, including designing drugs that don't block KIT or developing treatments to protect taste function. Future studies will aim to confirm these findings in patients and find ways to prevent or reduce taste changes.

#CancerTreatment #TasteBuds #MedicalResearch

Research shows that more than half of people receiving systemic anticancer treatment had a history of obesity, compared with only around one in four who were classified as obese at the time their treatment began.

Read Full Article

#ObesityAndCancer #CancerTreatment #OncologyResearch

🔬 CRISPR Breakthrough for Cancer Treatment: Utah State University (USU) biochemists have discovered that the CRISPR-Cas12a2 system can selectively destroy cells, offering a new potential approach to treating diseases like cancer without harming healthy tissue.

🧬 How it Works: Unlike other CRISPR systems, Cas12a2 uses a guide RNA to bind to RNA targets. When a perfect RNA match is found, Cas12a2 activates and shreds all DNA it encounters, effectively killing the cell. If the guide RNA isn't a perfect match, the cell is spared.

📊 Promising Results: Researchers demonstrated that Cas12a2 could selectively kill cancer cells with a specific mutation, leaving healthy cells untouched. In trials with mice, the therapy reduced tumor volume by approximately 50 percent after a single treatment.

🚀 Future Potential: This technology shows promise for selectively killing cells with specific gene mutations, viral genes, or other acquired changes, with potential applications in science, agriculture, and medicine.

#CRISPR #CancerTreatment #Biotechnology

Prescriptions for ivermectin and another antiparasitic drug among cancer patients shot up after actor Mel Gibson discussed an unproven treatment on Joe Rogan's popular podcast, according to a new study.

Read Full Article

#IvermectinDebate #CancerTreatment #MelGibsonControversy